May 28, 2026 12:45PM
Feb 27, 2026 02:20PM
Jan 30, 2026 03:00PM
Jan 12, 2026 09:03AM
Nov 14, 2025 02:36PM
Sep 8, 2025 09:28AM
Sep 4, 2025 03:50PM Tevogen Bio estimates pipeline drug value at $250 million for cancer treatment
Sep 3, 2025 04:15PM
Aug 11, 2025 11:59AM
Aug 6, 2025 03:59PM
Aug 5, 2025 02:32PM
Aug 1, 2025 03:58PM
Aug 1, 2025 03:32PM
Jul 30, 2025 12:45PM Tevogen Bio reports 74% insider ownership of outstanding shares
Jul 28, 2025 11:54AM
Jul 18, 2025 12:39PM
May 30, 2025 11:01AM
May 23, 2025 03:57PM
Apr 30, 2025 03:52PM
Apr 29, 2025 01:48PM
Apr 28, 2025 04:38PM Tevogen Bio (TVGN) Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
Apr 9, 2025 02:46PM
Apr 7, 2025 04:00PM
Mar 25, 2025 01:11PM
Mar 3, 2025 12:54PM
Feb 14, 2025 01:17PM
Feb 14, 2025 11:57AM
Feb 7, 2025 02:57PM Tevogen Bio (TVGN) Meets BARDA TechWatch Team, Highlighting ExacTcell Technology’s Potential as a Scalable Medical Countermeasure
Jan 28, 2025 03:50PM
Nov 8, 2024 03:38PM
Nov 5, 2024 09:28AM
Oct 31, 2024 10:57AM
Oct 29, 2024 03:43PM
Oct 29, 2024 12:44PM
Oct 21, 2024 04:01PM Tevogen Bio (TVGN) Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
Oct 21, 2024 01:57PM
Oct 17, 2024 09:34AM
Oct 15, 2024 11:36AM
Oct 11, 2024 04:00PM
Oct 11, 2024 12:12PM
Oct 8, 2024 02:40PM
Jul 11, 2024 12:21PM Tevogen Bio (TVGN) Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
Jun 11, 2024 03:31PM

413,150 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All